Connexon Creative Launches Mammary Cell News
Mammary Cell News is a weekly e-newsletter that keeps members of the mammary cell community informed by providing the latest news from all areas of the field, including its science, research and business.
Embryonic Stem Cell News
Neural Cell News
View Archived Issues
STEMSOFT(R) Software Inc. Licenses StemLab(R) Software to Carter BloodCare
STEMSOFT Software Inc (“STEMSOFT”), the leading provider software solutions for cell therapy transplant, is pleased to announce the licensing of StemLab, the leading cell therapy and cord blood banking laboratory software, to Carter BloodCare’s Stem Cell Transplant Laboratory in Bedford, TX.
Roche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates
Tekmira Pharmaceuticals Corporation announced recently that it has entered into a product development agreement with Roche to advance Roche’s first two RNA interference product candidates into human clinical testing.
ExcellGene and Kuhner Achieved Milestone in Development of Novel 250 Liter Mammalian Cell Culture Bioreactors
As part of a long-term partnership the two companies disclosed recently the successful conclusion of the technically challenging task of growing mammalian cells for the production of recombinant proteins in an orbitally shaken bioreactor.
Advanced Cell Technology Provides Single Blastomere Technology To CHA Bio & Diostech Co., Ltd.
Advanced Cell Technology, Inc. and CHA Bio & Diostech Co., Ltd. announced recently that the parties have entered into a licensing agreement under which Advanced Cell will license its proprietary “single blastomere technology,” to CHA Bio for development and commercialization exclusively in Korea.
Maryland Stem Cell Research Commission Announces 59 Projects for Funding
The Maryland Stem Cell Research Commission has completed its evaluation of the 147 applications in response to its three official Requests for Applications.
Lonza Expands Cell Therapy Business with New Facility in Singapore
Lonza Group Ltd is expanding its Cell Therapy business with the construction of a new facility in Singapore.
China to Invest $9.2 Bln in New Technology
China will spend 62.8 billion yuan ($9.2 billion) this year and the next on new technology as part of its efforts to stimulate economic growth, the State Council said on Wednesday.
Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Children’s Hospital Boston and Massachusetts General Hospital
Fate Therapeutics, Inc. announced recently that it has acquired exclusive intellectual property rights jointly owned by Children’s Hospital Boston and Massachusetts General Hospital.
NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases
NeoStem, Inc. announced recently it has signed an exclusive royalty-bearing license agreement for the Asia territory to use an innovative process that rapidly grows a patient’s own adult stem cells to treat a variety of musculoskeletal diseases.
Stem Cell Patent Digests
The UKNSCN has embarked upon a pilot project to provide the community with regular digests of both published and granted patents in the stem cell field.
U.S. Patent Office Upholds StemCells’ Patents – Company Moves to Resume Patent Infringement Cases Against Neuralstem
StemCells, Inc. announced recently that the U.S. Patent and Trademark Office has upheld the validity of the remaining two neural stem cell patents which were subjected to reexamination proceedings commenced by Neuralstem, Inc.